Space1 min read

Why pharma firms are going to Earth’s orbit in search of new cancer drugs

By · Via The Guardian Science · Published by Everything Blog

In short

Microgravity allows scientists to grow more ordered crystals, which improves drug solubility and shelf-life while opening new possibilities for high-tech semiconductors and graphene. California-based Varda Space Industries is leading this commercial shift by deploying uncrewed, autonomous capsules that manufacture products 300 miles above Earth without human interference. These specialized capsules re-enter the atmosphere at hypersonic speeds and parachute back down with their payloads. Following recent launches, the company intends to rapidly scale manufacturing flights over the next four years.

Key points

  • Producing drugs in orbit can improve stability and dissolve rates, potentially allowing i…: Producing drugs in orbit can improve stability and dissolve rates, potentially allowing intravenous infusions to be reformulated into simple injections.
  • Autonomous free-flyer capsules avoid the human vibrations and safety limitations that con…: Autonomous free-flyer capsules avoid the human vibrations and safety limitations that constrain manufacturing on the International Space Station.
  • Space-based manufacturing capabilities are expanding to high-performance materials beyond…: Space-based manufacturing capabilities are expanding to high-performance materials beyond medicine, including advanced semiconductors and graphene.

Sources checked by our analysis pipeline: 1

Roughly 300 miles above our heads, three washing machine-sized capsules are orbiting the Earth. Inside one of them, tiny crystals of a potential cancer drug are being grown in the weightlessness of space. The others are testing heat protection materials and navigation systems for when the capsules plunge back through Earth’s atmosphere at hypersonic speeds. Together, they represent a small but significant step towards what some hope will become a lucrative new industry: manufacturing drugs and other materials in space.

The spacecraft belong to California-based Varda Space Industries. On 1 October, it launched two onboard the same rocket, followed by the third on 20 October. With a record three spacecraft now simultaneously in orbit for the first time, the company is edging closer to its ambition of operating a fleet of orbiting pharmaceutical factories.

“We’re the first company in human history to launch multiple commercial re-entry vehicles simultaneously, and as the frequency of launches increases, the once ‘crazy future’ of manufacturing products in space is becoming more and more certain,” said Will Bruey, Varda’s chief executive.

There are several reasons…

Space